Locog Unveils Anti-doping Lab
The London Organising Committee of the Olympic and Paralympic Games has unveiled the WADA accredited anti-doping laboratory that will operate during the London 2012 Games.
LOCOG, laboratory service providers GlaxoSmithKline (GSK) and laboratory operators King’s College London, welcomed Hugh Robertson, Minister for Sport and the Olympics, for a tour of the facility based in Harlow, Essex.
Over 6,250 samples will be analysed throughout the Olympic and Paralympic Games, up to 400 each day and more than at any other Games.
The laboratory, which measures the size of seven tennis courts, will be in operation 24 hours a day, seven days a week.
Over 1,000 LOCOG staff will work within the Anti-Doping process and a team of more than 150 anti-doping scientists will carry out the testing, led independently by Professor David Cowan from the Drug Control Centre at King’s College London.
The facility, which has been provided by GSK, will be operated by anti-doping experts from King’s College London and supported by scientists from around the world.
Paul Deighton, London 2012 chief executive, said: ‘Today is an important milestone in the countdown to the Games. Working with one of the world’s best pharmaceutical companies and one of the country’s leading universities we have been able to create a facility to successfully and efficiently process 6,250 tests during the Games which has never been done before.’
‘As we unveil the anti-doping lab we recognise the importance of a robust testing system and continue to show that London is ready to stage a successful Games.’
Hugh Robertson added: ‘We are doing all we can to ensure that there is no place to hide for drug cheats at London 2012. Our message to any athlete thinking about doping is simple – we’ll catch you. This lab, from GlaxoSmithKline and King’s College London, is at the forefront of the fight against doping. It will be populated with scientists at the top of their field during the Games who will carry out an exhaustive testing process.’
Professor David Cowan, director of King’s College London’s Drug Control Centre commented: ‘These laboratories are the most high-tech labs in the history of the Games, analysing more samples than ever before. We have developed, with GSK support, super-fast and super-sensitive technologies to be able to detect use of prohibited substances. Our role is to ensure the efficient and effective operation of the lab to deliver robust anti-doping testing for the Games.’
In July 2011, GSK signed an agreement with the World Anti-Doping Agency (WADA) to share information about its medicines in development.
